• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

TurtleTree Scientific and Dyadic to Develop Affordable Growth Factors for Cell-Based Proteins at Scale

by Jennifer Marston
February 2, 2021February 2, 2021Filed under:
  • Alternative Protein
  • Biomanufacturing
  • Business of Food
  • Cultured Meat
  • Education & Discovery
  • Featured
  • Foodtech
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)

TurtleTree Scientific, the recently launched B2B unit of TurtleTree Labs that develops growth factors for cellular ag, today announced a “fully funded” collaboration with biotech company Dyadic International. Through this partnership, the two will develop recombinant food-grade growth factors for proteins that can be grown in high yields at lower costs in bioreactors. This could allow TurtleTree, which makes cell-cultured products (including human breastmilk) to scale up and get to market faster, paving the way for cultured meat and dairy companies to do the same.

Dyadic is known for its its C1 gene expression based on the Thermothelomyces heterothallica fungus. Via this platform, Dyadic can produce recombinant proteins at an industrial scale of up to 500,000 liters, with lower capital and operating expenditures than what cultured meat companies would normally find. The company’s tech has been used by some of the world’s most well-known biotech companies, including DuPont and BASF.

In a statement, TurtleTree cofounder and Chief Strategist Max Rye said that manufacturing human growth factors both at scale and at an affordable cost has been a major challenge, and that the partnership with Dyadic will help the company “overcome this hurdle” safely and efficiently.

Growth factors account for the bulk of the cost in cell-based protein production — 55 to 95 percent, by some accounts. Part of the reason for this, TurtleTree explained last month, is that cell culture media components have been developed for non-food areas like research and theraputics, which do not have the same scale requirements and cost constraints as food and agriculture production.

Ronen Tchelet, PhD, Dyadic’s Vice President of Research and Business Development, said in today’s press release that the company will engineer “hyper-productive” C1 cel lines to develop high bioactivity and yields suitable for commercial-scale productions. This will not only accelerate the timeline for TurtleTree’s business, it could also, according to Rye, “make cellular agriculture a reality for all” by enabling food-grade growth factors at an affordable price point to the wider cellular ag industry.


Related

TurtleTree Scientific Partners With JSBiosciences to Develop Cell Culture Media at Commercial Scale

TurtleTree Scientific, the B2B arm of cellular ag company TurtleTree Labs, announced today a new partnership with JSBiosciences to collaborate on the development of cell culture media. The overarching goal of the partnership is to bring down the cost of production for cell-cultured products in order to eventually achieve commercial…

TurtleTree Labs Raises $6.2M for its Cell-Cultured Milk

TurtleTree Labs, which is best known for developing cell-based human breastmilk, announced today that it has raised a $6.2 million Pre-A round of funding. Green Monday Ventures, Eat Beyond Global, KBW Ventures, and Verso Capital all participated in the round. This brings the total amount of announced funding for the…

TurtleTree Labs Raises $3.2M Seed Round for its Cultured Human Breast Milk

Turtle Tree Labs, a Singapore-based startup that creates milk from mammalian cells, announced yesterday that it has raised a $3.2 million seed round of funding. Green Monday Ventures, KBW Ventures, CPT Capital, Artesian, and New Luna Ventures all participated in the round. As we've covered previously, TurtleTree Labs uses cellular…

Get the Spoon in your inbox

Just enter your email and we’ll take care of the rest:

Find us on some of these other platforms:

  • Apple Podcasts
  • Spotify
Tagged:
  • alternative protein
  • cultured meat
  • cultured protein
  • Dyadic
  • TurtleTree Labs
  • TurtleTree Scientific

Post navigation

Previous Post McDonald’s Starts Testing McPlant Burger in Europe
Next Post Vivino Raises $155M Series D for its Wine App and Online Marketplace

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Get The Spoon in Your Inbox

The Spoon Podcast Network!

Feed your mind! Subscribe to one of our podcasts!

How ReShape is Using AI to Accelerate Biotech Research
How Eva Goulbourne Turned Her ‘Party Trick’ Into a Career Building Sustainable Food Systems
Combustion Acquires Recipe App Crouton
Next-Gen Fridge Startup Tomorrow Shuts Down
From Starday to Shiru to Givaudan, AI Is Now Tablestakes Across the Food Value Chain

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.